dr. garcia on fda approval of pembrolizumab in bladder cancer
Published 7 years ago • 178 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
0:38
dr. siefker-radtke on fda approval of avelumab in bladder cancer
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
0:55
dr. siefker-radtke on fda approval of frontline atezolizumab in bladder cancer
-
1:49
fda approval of durvalumab for bladder cancer
-
7:05
the fda approval of atezolizumab in bladder cancer
-
6:49
fda approval of atezolizumab for advanced bladder cancer
-
1:28
dr. garcia on selecting second-line immunotherapy in bladder cancer
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer
-
0:53
dr. siefker-radtke on fda approval of durvalumab in bladder cancer
-
1:44
dr. ferris on impact of fda approval of pembrolizumab in patients with head and neck cancer
-
2:03
durvalumab fda approval for bladder cancer
-
0:51
dr. balar on the approval of pembrolizumab for bladder cancer
-
1:21
dr. rosenberg on immunotherapeutic advances in bladder cancer
-
8:18
current state and future directions in bladder cancer
-
1:18
dr. plimack on combo of pembrolizumab/epacodostat in bladder cancer
-
8:43
fda approvals in bladder cancer and nsclc, and 2019 elcc highlights
-
2:03
dr. agustin a. garcia on everolimus/exemestane and anastrozole/fulvestrant
-
1:05
dr. garcia on a trial analyzing the parp inhibitor veliparib